Laurion Capital Management LP Laboratory Corp Of America Holdings Transaction History

Laurion Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $395,577 - $454,807	2,001 New	2,001 $454,000
Q3 2020 Nov 13, 2020	SELL	$167.03 - $201.3 $570,908 - $688,043	-3,418 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $387,293 - $623,579	3,418 New	3,418 $568,000
Q1 2020 May 14, 2020	SELL	$104.32 - $195.28 $563,328 - $1.05 Million	-5,400 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$163.48 - $173.61 $882,792 - $937,494	5,400 New	5,400 $914,000
Q4 2018 Feb 14, 2019	SELL	$120.82 - $174.09 $276,919 - $399,014	-2,292 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$167.67 - $188.27 $1.16 Million - $1.3 Million	-6,908 Reduced 75.09%	2,292 $398,000
Q2 2018 Aug 13, 2018	SELL	$160.33 - $189.41 $448,924 - $530,348	-2,800 Reduced 23.33%	9,200 $1.65 Million
Q1 2018 May 14, 2018	SELL	$161.53 - $178.11 $1.68 Million - $1.85 Million	-10,400 Reduced 46.43%	12,000 $1.94 Million
Q4 2017 Feb 13, 2018	BUY	$147.99 - $163.95 $2.44 Million - $2.7 Million	16,473 Added 277.93%	22,400 $3.57 Million
Q3 2017 Nov 13, 2017	BUY	$149.47 - $160.56 $885,908 - $951,639	5,927	5,927 $895,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.